{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Repligen Corporation"},"Symbol":{"label":"Symbol","value":"RGEN"},"Address":{"label":"Address","value":"41 SEYON STREET, BUILDING 1,SUITE 100, WALTHAM, Massachusetts, 02453, United States"},"Phone":{"label":"Phone","value":"+1 781 250-0111"},"Industry":{"label":"Industry","value":"Biotechnology: Biological Products (No Diagnostic Substances)"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Repligen Corp is a global life sciences company. It develops and commercializes innovative bioprocessing technologies and systems that increase efficiencies and flexibility in the process of manufacturing biological drugs. The company's customers include life science companies, global biopharmaceutical companies, and contract manufacturers worldwide. Repligen markets its products globally through a direct commercial organization in the U.S., Europe, and Asia, as well as through strategic partners in select markets. The majority of the company's revenue is generated in North America."},"CompanyUrl":{"label":"Company Url","value":"https://www.repligen.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"James R. Bylund","title":"Chief Operating Officer"},{"name":"Keith Lee Robinson","title":"Chief Information Officer"},{"name":"Ralf Kuriyel","title":"Senior Vice President-Research & Development"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}